These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9639703)

  • 1. Genotoxic activity of four inhibitors of DNA topoisomerases in larval cells of Drosophila melanogaster as measured in the wing spot assay.
    Torres C; Creus A; Marcos R
    Mutat Res; 1998 Mar; 413(2):191-203. PubMed ID: 9639703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of somatic mutation and recombination by four inhibitors of eukaryotic topoisomerases assayed in the wing spot test of Drosophila melanogaster.
    Frei H; Würgler FE
    Mutagenesis; 1996 Jul; 11(4):315-25. PubMed ID: 8671755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxic profile of inhibitors of topoisomerases I (camptothecin) and II (etoposide) in a mitotic recombination and sex-chromosome loss somatic eye assay of Drosophila melanogaster.
    Sortibrán AN; Téllez MG; Rodríguez-Arnaiz R
    Mutat Res; 2006 Apr; 604(1-2):83-90. PubMed ID: 16529987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sister-chromatid exchanges (SCE) induction by inhibitors of DNA topoisomerases in cultured human lymphocytes.
    Ribas G; Xamena N; Creus A; Marcos R
    Mutat Res; 1996 Jul; 368(3-4):205-11. PubMed ID: 8692226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxic activity of different chromium compounds in larval cells of Drosophila melanogaster, as measured in the wing spot test.
    Amrani S; Rizki M; Creus A; Marcos R
    Environ Mol Mutagen; 1999; 34(1):47-51. PubMed ID: 10462723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxicity testing of five herbicides in the Drosophila wing spot test.
    Kaya B; Yanikoglu A; Creus A; Marcos R
    Mutat Res; 2000 Feb; 465(1-2):77-84. PubMed ID: 10708972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity studies on the phenoxyacetates 2,4-D and 4-CPA in the Drosophila wing spot test.
    Kaya B; Yanikoglu A; Marcos R
    Teratog Carcinog Mutagen; 1999; 19(4):305-12. PubMed ID: 10406894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of camptothecin derivatives presently in clinical trials: genotoxic potency and mitotic recombination.
    Cunha KS; Reguly ML; Graf U; Rodrigues de Andrade HH
    Mutagenesis; 2002 Mar; 17(2):141-7. PubMed ID: 11880543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sodium arsenite on the genotoxicity of potassium dichromate and ethyl methanesulfonate: studies with the wing spot test in Drosophila.
    Rizki M; Kossatz E; Xamena N; Creus A; Marcos R
    Environ Mol Mutagen; 2002; 39(1):49-54. PubMed ID: 11813296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The somatic white-ivory eye spot test does not detect the same spectrum of genotoxic events as the wing somatic mutation and recombination test in Drosophila melanogaster.
    Graf U; Würgler FE
    Environ Mol Mutagen; 1996; 27(3):219-26. PubMed ID: 8625958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity modulation by cadmium treatment: studies in the Drosophila wing spot test.
    Rizki M; Kossatz E; Creus A; Marcos R
    Environ Mol Mutagen; 2004; 43(3):196-203. PubMed ID: 15065207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinagenic activity of four compounds in the standard and high bioactivation crosses of Drosophila melanogaster in the wing spot test.
    Spanó MA; Frei H; Würgler FE; Graf U
    Mutagenesis; 2001 Sep; 16(5):385-94. PubMed ID: 11507237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity of several clinically used topoisomerase II inhibitors.
    Boos G; Stopper H
    Toxicol Lett; 2000 Jul; 116(1-2):7-16. PubMed ID: 10906417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
    D'Arpa P; Beardmore C; Liu LF
    Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of mitotic recombination induced by several mono- and bifunctional alkylating agents in the Drosophila wing-spot test.
    Rodriguez-Arnaiz R; Soto PO; Oyarzún JC; Graf U
    Mutat Res; 1996 Apr; 351(2):133-45. PubMed ID: 8622707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis.
    Sumner AT
    J Cell Sci; 1992 Sep; 103 ( Pt 1)():105-15. PubMed ID: 1331132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8.
    Cortés F; Piñero J; Palitti F
    Mutat Res; 1993 Aug; 288(2):281-9. PubMed ID: 7688089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of transfluthrin and metofluthrin genotoxicity in the ST cross of the Drosophila Wing Spot Test.
    Sarıkaya R; Memmi BK
    Chemosphere; 2013 Sep; 93(2):238-42. PubMed ID: 23725752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA.
    Nitiss JL; Wang JC
    Mol Pharmacol; 1996 Nov; 50(5):1095-102. PubMed ID: 8913340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.